The present invention relates to a crystalline form of abemaciclib, a method of preparing the same, as well as a pharmaceutical composition comprising the same.La présente invention concerne un nouveau abemaciclib de forme cristalline, son procédé de préparation ainsi quune composition pharmaceutique le contenant.